The transformational grant will launch a new center led by Dr. Fanny Elahi to pursue treatments for understudied neurovascular diseases
The Mount Sinai Health System has received an $8 million grant from DataPhilanthropy to fuel urgently needed research into CADASIL, a genetic disease associated with changes to small blood vessels causing migraines, strokes, cognitive decline, and dementia. The funding, administered by DataPhilanthropy, will establish a first-of-its-kind translational center dedicated to development of treatments for cerebral small vessel diseases for successful aging across the lifespan. The effort will be led by Fanny Elahi, MD, PhD, a renowned physician-scientist and one of the world’s foremost experts on ?neurovascular degenerative disorders and CADASIL.?
“With no existing treatments for CADASIL, this generous grant gives us the freedom to move quickly, ask bold scientific questions, and pursue multiple promising paths toward treatments,” said Dr. Elahi.